Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Working together, these hormones keep blood sugar in check, slow the movement of food through the gut and signal the brain about…

Read original article on Medical Xpress - latest medical and health news stories →